PDF(Pubmed)
Abstract：
UNASSIGNED: Neonatal hypoglycemia (NH) is a common clinical symptom that can occur in both normal and critically ill neonates. The placenta is the site of material exchange between the mother and the fetus, a special organ shared by the mother and the fetus during pregnancy, and one of its important functions is to transfer nutrients from the mother to the fetus. Terbutaline is used to relax frequent uterine contractions before delivery, and it can penetrate the placental barrier and affect the normal decomposition of neonatal glycogen. The situation is neonatal hypoglycemia if not timely detection and interventions in time, the neonate may have recurrent hypoglycemia, leading to irreversible nervous system damage, such as neonatal hypoglycemic encephalopathy, and visual and cognitive impairment.
UNASSIGNED: The male neonate was a single fetus, with a birth weight of 3660 g and a length of 50 cm. The blood glucose at birth was 5 mmol/L, Apgar score was 9-10, and body temperature was normal. The mother was healthy, was not diabetic, and had no other risk factors for neonatal hypoglycemia. She was injected with 0.25 mg of terbutaline 6 hours before delivery due to frequent uterine contractions. However, it was found that recurrent hypoglycemia occurred in the neonate even after adequate oral feeding.
UNASSIGNED: We included evidence-based use of terbutaline 48 hours before delivery as a high-risk factor for hypoglycemia in the rooming-in neonatal hypoglycemia care program, and formulate the corresponding nursing process, with good effect.
UNASSIGNED: The male neonate was a single fetus, with a birth weight of 3660 g and a length of 50 cm. The blood glucose at birth was 5 mmol/L, Apgar score was 9-10, and body temperature was normal. The mother was healthy, was not diabetic, and had no other risk factors for neonatal hypoglycemia. She was injected with 0.25 mg of terbutaline 6 hours before delivery due to frequent uterine contractions. However, it was found that recurrent hypoglycemia occurred in the neonate even after adequate oral feeding.
UNASSIGNED: We included evidence-based use of terbutaline 48 hours before delivery as a high-risk factor for hypoglycemia in the rooming-in neonatal hypoglycemia care program, and formulate the corresponding nursing process, with good effect.
摘要：
■新生儿低血糖（NH）是一种常见的临床症状，可发生在正常和危重新生儿中。胎盘是母亲和胎儿之间物质交换的部位，母亲和胎儿在怀孕期间共享的特殊器官，它的重要功能之一是将营养从母亲转移到胎儿。特布他林用于在分娩前放松频繁的子宫收缩，能穿透胎盘屏障，影响新生儿糖原的正常分解。情况是新生儿低血糖如果没有及时发现和及时干预,新生儿可能有反复的低血糖,导致不可逆的神经系统损伤,如新生儿低血糖脑病，视觉和认知障碍。
■男性新生儿是一个胎儿,出生体重3660克，身长50厘米。出生时血糖为5mmol/L,Apgar评分为9-10分，体温正常。母亲很健康，不是糖尿病患者,并且没有其他新生儿低血糖的危险因素。由于频繁的子宫收缩，她在分娩前6小时注射了0.25mg特布他林。然而,结果发现，即使在适当的口服喂养后，新生儿也会发生反复的低血糖。
■我们将分娩前48小时使用特布他林作为新生儿低血糖护理计划中低血糖的高危因素纳入循证治疗，并制定相应的护理流程,效果很好。
■男性新生儿是一个胎儿,出生体重3660克，身长50厘米。出生时血糖为5mmol/L,Apgar评分为9-10分，体温正常。母亲很健康，不是糖尿病患者,并且没有其他新生儿低血糖的危险因素。由于频繁的子宫收缩，她在分娩前6小时注射了0.25mg特布他林。然而,结果发现，即使在适当的口服喂养后，新生儿也会发生反复的低血糖。
■我们将分娩前48小时使用特布他林作为新生儿低血糖护理计划中低血糖的高危因素纳入循证治疗，并制定相应的护理流程,效果很好。
